跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,518 条关于
“GOG-0218”
全部
1,518
临床试验
942
药物
457
机构
18
资讯
101
去年
Real-World Study Confirms Bevacizumab Benefits Limited to High-Risk Epithelial Ovarian Cancer Patients
去年
FDA Signals Potential Traditional Approval Pathway for Genelux's Olvi-Vec in Platinum-Resistant Ovarian Cancer
11个月前
Faeth Therapeutics Raises $25M to Advance PIKTOR Therapy After 80% Response Rate in Endometrial Cancer
去年
Ribociclib-Letrozole Combo Shows Promising 24% Response Rate in Low-Grade Serous Ovarian Cancer Trial
2年前
Pembrolizumab Fails to Improve DFS in High-Risk Endometrial Cancer, Shows Promise in dMMR Subgroup
8个月前
FDA Grants Breakthrough Therapy Designation to Lilly's Sofetabart Mipitecan for Platinum-Resistant Ovarian Cancer
2年前
Advancements in Penile Cancer Treatment: ESMO 2024 Highlights Neoadjuvant Strategies and Immunotherapy
去年
ESMO Congress Highlights Immunotherapy Advancements in Multiple Cancers
去年
Mixed Results for Adjuvant Therapies in Solid Tumors: Key Takeaways From ESMO 2024
去年
Afuresertib Plus Paclitaxel Fails to Improve Survival in Platinum-Resistant Ovarian Cancer Trial
第 1 页,共 11 页
上一页
下一页